Alva Health
Techstars '21Dallas, US · Delaware corporation · 1 known investors
Alva Health develops wearable medical devices that continuously monitor for early signs of stroke and alert emergency responders in real time. The company serves patients at risk of stroke and the healthcare system, focusing on improving outcomes through rapid detection and treatment initiation.
Founders & leadership
Investors · 1
Competitors · 7
by search overlapCompanies competing with Alva Health for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$743KraisedMar 2023 · 17 investors · Other Health CareRule 506(b)
- Sandra SaldanaExecutive Officer, Director
- Amount sold
- $743K
- Minimum investment
- $25K
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase II | 2021 | $1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $257K |
| National Science Foundation | Phase I | 2019 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
- Avena targets U.S. market with scaled digital health infrastructure — TFNtechfundingnews.com · 2026
- The Dallas Healthtech Founder Launching a Wearable Stroke Detection Breakthrough featuring Alva Health - MedTech Innovatormedtechinnovator.org · 2025
- Alva Health Wins $500,000 in R&D Funding from the U.S. National Science Foundation - MedTech Innovatormedtechinnovator.org · 2025